Engels Chou

943 total citations · 1 hit paper
10 papers, 571 citations indexed

About

Engels Chou is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Engels Chou has authored 10 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Infectious Diseases. Recurrent topics in Engels Chou's work include Mycobacterium research and diagnosis (5 papers), Diabetes Management and Research (4 papers) and Diabetes Treatment and Management (4 papers). Engels Chou is often cited by papers focused on Mycobacterium research and diagnosis (5 papers), Diabetes Management and Research (4 papers) and Diabetes Treatment and Management (4 papers). Engels Chou collaborates with scholars based in United States, United Kingdom and Germany. Engels Chou's co-authors include Brian Seal, Ion Cotarla, Alyssa Klein, Apar Kishor Ganti, Quanwu Zhang, Gina Eagle, Theodore K. Marras, Charles M. Gerrits, Raymond Zhang and Keith Hamilton and has published in prestigious journals such as BMJ Open, JAMA Oncology and Respiratory Medicine.

In The Last Decade

Engels Chou

10 papers receiving 561 citations

Hit Papers

Update of Incidence, Prevalence, Survival, and Initial Tr... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Engels Chou United States 7 270 197 118 104 91 10 571
Amelia Szymanowska Poland 12 282 1.0× 254 1.3× 54 0.5× 261 2.5× 51 0.6× 32 622
Mahadi Baig United States 11 86 0.3× 91 0.5× 61 0.5× 72 0.7× 63 0.7× 42 344
Mark Matson United States 10 112 0.4× 78 0.4× 49 0.4× 151 1.5× 69 0.8× 25 577
Myla Lai-Goldman United States 10 94 0.3× 255 1.3× 29 0.2× 146 1.4× 84 0.9× 14 473
Jan Willem de Groot Netherlands 12 153 0.6× 330 1.7× 35 0.3× 185 1.8× 37 0.4× 55 629
Tomoyuki Otsuka Japan 13 170 0.6× 166 0.8× 32 0.3× 116 1.1× 79 0.9× 66 541
Alan T. Remaley United States 9 173 0.6× 48 0.2× 102 0.9× 90 0.9× 35 0.4× 12 480
Levent Dizdar Germany 16 83 0.3× 242 1.2× 51 0.4× 174 1.7× 76 0.8× 30 474
Adalet Demir Türkiye 16 390 1.4× 85 0.4× 17 0.1× 96 0.9× 40 0.4× 36 623
J.M. Cózar Spain 14 351 1.3× 224 1.1× 66 0.6× 118 1.1× 57 0.6× 67 773

Countries citing papers authored by Engels Chou

Since Specialization
Citations

This map shows the geographic impact of Engels Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engels Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engels Chou more than expected).

Fields of papers citing papers by Engels Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Engels Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engels Chou. The network helps show where Engels Chou may publish in the future.

Co-authorship network of co-authors of Engels Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Engels Chou. A scholar is included among the top collaborators of Engels Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Engels Chou. Engels Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ganti, Apar Kishor, Alyssa Klein, Ion Cotarla, Brian Seal, & Engels Chou. (2021). Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US. JAMA Oncology. 7(12). 1824–1824. 387 indexed citations breakdown →
2.
Marras, Theodore K., Christopher Vinnard, Quanwu Zhang, et al.. (2018). Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population. Respiratory Medicine. 145. 80–88. 41 indexed citations
3.
Winthrop, Kevin, Jennifer Adjemian, Mehdi Mirsaeidi, et al.. (2018). 780. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare, 2008–2015. Open Forum Infectious Diseases. 5(suppl_1). S279–S280. 1 indexed citations
4.
Marras, Theodore K., Mehdi Mirsaeidi, Engels Chou, et al.. (2018). Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States. Journal of Managed Care & Specialty Pharmacy. 24(10). 964–974. 21 indexed citations
5.
Deshpande, Chinmay, et al.. (2018). Validation of the Nontuberculous Mycobacteria (NTM) Module in NTM Lung Disease. PA342–PA342. 1 indexed citations
6.
Chou, Engels, et al.. (2017). Economic burden of hypoglycemia with basal insulin in type 2 diabetes.. PubMed. 23(2). 114–122. 14 indexed citations
8.
Freemantle, Nick, Engels Chou, Ying Daisy Zhuo, et al.. (2016). Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis. BMJ Open. 6(2). e009421–e009421. 49 indexed citations
9.
Raccah, D., Engels Chou, Stephen Colagiuri, et al.. (2016). A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin. Diabetes/Metabolism Research and Reviews. 33(3). 38 indexed citations
10.
Pscherer, Stefan, Engels Chou, Franz‐Werner Dippel, Wolfgang Rathmann, & Karel Kostev. (2015). Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis. Primary care diabetes. 9(5). 377–384. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026